Shares of Waldencast PLC (NASDAQ:WALD – Get Free Report) have been given an average recommendation of “Hold” by the five analysts that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $3.20.
Several brokerages have weighed in on WALD. Jefferies Financial Group began coverage on Waldencast in a report on Wednesday, January 14th. They issued a “buy” rating and a $2.00 price target for the company. Telsey Advisory Group cut their price target on Waldencast from $3.00 to $2.00 and set a “market perform” rating for the company in a report on Monday, March 16th. Canaccord Genuity Group cut their price target on Waldencast from $4.00 to $2.00 and set a “buy” rating for the company in a report on Monday, March 16th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Waldencast in a report on Wednesday, January 21st.
Read Our Latest Stock Report on WALD
Institutional Trading of Waldencast
Waldencast Price Performance
Shares of WALD opened at $0.99 on Tuesday. The stock has a fifty day moving average of $1.53 and a two-hundred day moving average of $1.81. The company has a current ratio of 1.70, a quick ratio of 0.97 and a debt-to-equity ratio of 0.29. Waldencast has a fifty-two week low of $0.86 and a fifty-two week high of $3.22.
About Waldencast
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.
Further Reading
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.
